COM:KURAONCOLOGY
Kura Oncology, Inc.
- Stock
Last Close
15.91
21/11 21:00
Market Cap
1.55B
Beta: -
Volume Today
16.29M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | ||||||||||||
average payables | 1.10K - | 180.18K 16,279.55% | 1.10M 510.24% | 1.62M 47.66% | 1.44M 11.55% | 2.79M 94.43% | 3.82M 36.93% | 3.14M 17.88% | 2.99M 4.62% | 2.38M 20.37% | 766.50K 67.85% | |
average receivables | 15K - | 230K 1,433.33% | 362.50K 57.61% | 255.50K 29.52% | 220K 13.89% | 127K 42.27% | 15K 88.19% | |||||
book value per share | -0.02 - | -0.24 854.46% | -2.65 1,018.79% | -2.88 8.78% | -3.84 33.43% | -4.25 10.73% | -5.08 19.27% | -5.70 12.30% | -6.53 14.49% | -8.49 30.12% | 5.43 163.89% | |
capex per share | -0.01 - | -0.04 - | -0.02 57.74% | -0.01 45.94% | ||||||||
capex to depreciation | -3.20 - | -11.19 - | -2.06 81.63% | -0.82 59.88% | ||||||||
capex to operating cash flow | 0.00 - | 0.03 - | 0.01 64.71% | 0.01 48.16% | ||||||||
capex to revenue | ||||||||||||
cash per share | 0.00 - | 0.08 5,797.80% | 8.63 11,042.43% | 3.62 58.01% | 4.01 10.58% | 5.09 26.88% | 5.65 11.04% | 11.93 111.28% | 7.81 34.58% | 6.54 16.25% | 5.79 11.45% | |
days of inventory on hand | ||||||||||||
days payables outstanding | 5.62 - | 5.50K 97,710.44% | ||||||||||
days sales outstanding | ||||||||||||
debt to assets | 24.26 - | 1.84 92.44% | 0.10 - | 0.07 29.40% | 0.04 44.47% | 0.03 24.63% | 0.02 25.34% | 0.01 44.37% | 0.03 138.74% | 0.04 24.66% | ||
debt to equity | -1.77 - | -0.74 58.49% | -0.14 - | -0.08 41.55% | -0.05 36.99% | -0.04 29.66% | -0.05 40.53% | -0.02 67.93% | -0.02 55.27% | 0.04 275.60% | ||
dividend yield | ||||||||||||
earnings yield | -0.00 - | -0.02 4,531.70% | -0.27 1,507.49% | -0.25 7.88% | -0.10 60.10% | -0.12 22.75% | -0.11 10.52% | -0.05 52.87% | -0.14 171.07% | -0.16 17.04% | -0.14 11.44% | |
enterprise value | 75.21M - | 219.03M 191.21% | 67.99M 68.96% | 107.93M 58.74% | 351.19M 225.37% | 485.46M 38.23% | 558.12M 14.97% | 1.42B 154.96% | 845.13M 40.61% | 793.57M 6.10% | 1.03B 30.16% | |
enterprise value over ebitda | -3.37K - | -59.78 98.22% | -2.85 95.23% | -3.80 33.55% | -9.73 155.84% | -7.72 20.69% | -8.27 7.14% | -15.48 87.21% | -6.44 58.42% | -5.67 11.88% | -6.77 19.27% | |
ev to operating cash flow | -3.08K - | -257.98 91.62% | -3.79 98.53% | -4.26 12.25% | -12.35 190.00% | -9.98 19.20% | -10.19 2.15% | -20.38 99.94% | -8.08 60.33% | -7.21 10.80% | -8.27 14.77% | |
ev to sales | ||||||||||||
free cash flow per share | -0.00 - | -0.06 1,098.27% | -1.81 2,994.79% | -1.36 25.15% | -1.22 9.70% | -1.38 12.96% | -1.31 5.58% | -1.36 3.91% | -1.59 17.43% | -1.65 3.72% | -1.70 3.16% | |
free cash flow yield | -0.00 - | -0.00 1,098.27% | -0.22 5,426.42% | -0.23 6.56% | -0.08 65.18% | -0.10 23.10% | -0.09 3.59% | -0.04 56.25% | -0.11 173.95% | -0.13 17.01% | -0.12 10.97% | |
graham net net | -0.03 - | -0.25 898.69% | 8.15 3,325.03% | 2.94 63.85% | 3.33 13.00% | 4.48 34.72% | 5.10 13.66% | 11.25 120.76% | 7.39 34.28% | 6.00 18.84% | 5.08 15.27% | |
graham number | 0.06 - | 1.16 2,002.57% | 11.65 903.56% | 9.77 16.11% | 11.48 17.50% | 12.82 11.68% | 13.11 2.24% | 14.70 12.12% | 16.95 15.34% | 19.70 16.19% | 15.95 19.03% | |
income quality | 0.89 - | 0.23 74.13% | 0.79 242.57% | 0.92 16.09% | 0.80 12.73% | 0.80 0.28% | 0.87 7.75% | 0.78 10.16% | 0.80 2.85% | 0.81 1.11% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -4.49 - | -669.39 14,803.28% | -271.19 59.49% | -49.16 81.87% | -40.63 17.36% | -64.83 59.57% | -116.34 79.46% | -159.33 36.95% | -318.40 99.83% | -614.08 92.87% | 98.54 116.05% | |
interest debt per share | 0.04 - | 0.17 288.31% | 0.01 94.93% | 0.42 4,668.86% | 0.34 18.65% | 0.24 29.97% | 0.19 19.97% | 0.29 52.14% | 0.11 62.52% | 0.21 93.68% | 0.21 0.45% | |
inventory turnover | ||||||||||||
invested capital | -1.77 - | -0.74 58.49% | -0.14 - | -0.08 41.55% | -0.05 36.99% | -0.04 29.66% | -0.05 40.53% | -0.02 67.93% | -0.02 55.27% | 0.04 275.60% | ||
market cap | 75M - | 217.62M 190.16% | 83.44M 61.66% | 110.34M 32.24% | 355.53M 222.22% | 494.08M 38.97% | 576.76M 16.73% | 1.73B 200.56% | 928.93M 46.41% | 831.35M 10.50% | 1.05B 26.67% | |
net current asset value | -126.46K - | -3.62M 2,758.68% | 81.71M 2,360.39% | 55.87M 31.63% | 78.66M 40.79% | 159.80M 103.17% | 216.41M 35.42% | 600.99M 177.70% | 494.85M 17.66% | 410.40M 17.07% | 380.82M 7.21% | |
net debt to ebitda | -9.55 - | -0.38 95.99% | 0.65 268.76% | 0.08 86.92% | 0.12 41.96% | 0.14 14.07% | 0.28 101.48% | 3.38 1,123.52% | 0.64 81.11% | 0.27 57.69% | 0.13 51.20% | |
net income per share | -0.01 - | -0.25 4,531.70% | -2.28 800.20% | -1.47 35.30% | -1.52 3.47% | -1.72 12.64% | -1.51 12.37% | -1.68 11.94% | -1.96 16.20% | -2.03 3.75% | -2.08 2.61% | |
operating cash flow per share | -0.00 - | -0.06 1,098.27% | -1.80 2,983.78% | -1.36 24.89% | -1.22 9.70% | -1.38 12.96% | -1.31 5.58% | -1.32 0.78% | -1.58 19.77% | -1.64 4.27% | -1.70 3.75% | |
payables turnover | 64.95 - | 0.07 99.90% | ||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | ||||||||||||
return on tangible assets | -3.01 - | -2.66 11.56% | -0.26 90.27% | -0.39 52.24% | -0.37 6.35% | -0.33 10.34% | -0.26 21.27% | -0.14 47.05% | -0.24 76.04% | -0.30 22.59% | -0.34 14.01% | |
revenue per share | ||||||||||||
roe | 0.22 - | 1.07 385.27% | 0.86 19.54% | 0.51 40.52% | 0.40 22.45% | 0.40 1.73% | 0.30 26.53% | 0.30 0.33% | 0.30 1.49% | 0.24 20.27% | -0.38 260.61% | |
roic | -0.23 - | 4.67 2,107.83% | 0.91 80.59% | 0.61 32.84% | 0.44 27.98% | 0.47 6.49% | 0.33 29.65% | 0.33 0.04% | 0.31 4.67% | 0.26 18.19% | -0.36 241.09% | |
sales general and administrative to revenue | ||||||||||||
shareholders equity per share | -0.02 - | -0.24 854.46% | -2.65 1,018.79% | -2.88 8.78% | -3.84 33.43% | -4.25 10.73% | -5.08 19.27% | -5.70 12.30% | -6.53 14.49% | -8.49 30.12% | 5.43 163.89% | |
stock based compensation to revenue | ||||||||||||
tangible asset value | -123.96K - | -3.43M 2,669.51% | 82.10M 2,491.58% | 56.88M 30.73% | 79.86M 40.42% | 160.99M 101.57% | 218.78M 35.90% | 610.90M 179.23% | 506.61M 17.07% | 420.28M 17.04% | 397.27M 5.47% | |
tangible book value per share | -0.02 - | -0.24 854.46% | 8.27 3,593.15% | 3.04 63.21% | 3.44 13.01% | 4.57 33.10% | 5.22 14.02% | 11.51 120.67% | 7.64 33.66% | 6.27 17.83% | 5.43 13.53% | |
working capital | -103.78K - | -1.82M 1,653.68% | 81.81M 4,595.27% | 63.36M 22.56% | 84.61M 33.54% | 167.58M 98.06% | 224.04M 33.69% | 611.27M 172.84% | 499.83M 18.23% | 422.37M 15.50% | 397.22M 5.95% |
All numbers in (except ratios and percentages)